Endo International plc announced today that its Par Sterile Products business has begun shipping bivalirudin injection in a ready-to-use 250 mg/50 mL single-use vial. It is the only ready-to-use liquid format of bivalirudin on the market in the U.S.

Umitomo Chemical Co., Ltd, one of Japan's leading chemical companies, and Ginkgo Bioworks which is building the leading platform for cell programming and biosecurity,

Beckman Coulter Diagnostics, a leader in clinical diagnostics, and Fujirebio, a leader in neurological markers and in vitro diagnostics, announced today the formation of a new

Scipher Medicine today announced that it has entered into a multi-disease area collaboration with Ionis Pharmaceuticals. In the collaboration, Ionis is responsible

Sangamo Therapeutics, Inc a genomic medicine company, today announced it has signed an evaluation and option agreement with Prevail Therapeutic a wholly owned

TauRx Pharmaceuticals Ltd., a global leader in Tau-based research in Alzheimer’s disease today announced results from a prespecified analysis of the Phase 3 LUCIDITY

Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases.

Acadia Pharmaceuticals Inc. today announced that it has expanded its current licensing agreement for trofinetide with Neuren Pharmaceuticals to acquire ex-North American

KSQ Therapeutics, Inc. a clinical-stage biotechnology company developing cancer therapies using its proprietary CRISPRomics® discovery platform, announced today

Credible, a San Francisco-headquartered, AI-powered ESG Company has onboarded Ajanta Pharma Ltd, a leading global pharmaceutical company to improve its ESG